Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History CODX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics CODX

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Co-Diagnostics Inc

CODX
Current price
0.25 USD -0.0019 USD (-0.75%)
Last closed 0.25 USD
ISIN US1897631057
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 8 492 178 USD
Yield for 12 month -80.54 %
1Y
3Y
5Y
10Y
15Y
CODX
21.11.2021 - 28.11.2021

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is based in Salt Lake City, Utah. Address: 2401 S. Foothill Dr., Salt Lake City, UT, United States, 84109

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

5.50 USD

P/E Ratio

Dividend Yield

Financials CODX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures CODX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+3 915 160 USD

Last Year

+6 812 038 USD

Current Quarter

+50 277 USD

Last Quarter

+149 325 USD

Current Year

+2 916 036 USD

Last Year

+2 627 089 USD

Current Quarter

+28 687 USD

Last Quarter

-105 743 USD
EBITDA -37 046 740 USD
Operating Margin TTM -17 009.68 %
Price to Earnings
Return On Assets TTM -33.82 %
PEG Ratio
Return On Equity TTM -56.80 %
Wall Street Target Price 5.50 USD
Revenue TTM 3 497 583 USD
Book Value 1.43 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -89.30 %
Dividend Yield
Gross Profit TTM 2 711 374 USD
Earnings per share -1.17 USD
Diluted Eps TTM -1.17 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY 30.80 %
Profit Margin

Stock Valuation CODX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 16.00
Enterprise Value Revenue 0.064
Price Sales TTM 2.43
Enterprise Value EBITDA 0.52
Price Book MRQ 0.20

Technical Indicators CODX

For 52 Weeks

0.23 USD 2.23 USD
50 Day MA 0.29 USD
Shares Short Prior Month 282 095
200 Day MA 0.68 USD
Short Ratio 0.41
Shares Short 283 384
Short Percent 0.91 %